Itron, Inc. (NASDAQ:ITRI) Given Average Rating of "Moderate Buy" by Analysts

Itron, Inc. (NASDAQ:ITRI - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $137.10.

A number of research firms have recently weighed in on ITRI. Stephens set a $130.00 target price on shares of Itron in a report on Monday, August 4th. Guggenheim reiterated a "buy" rating and set a $155.00 price target (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. TD Cowen lifted their target price on shares of Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, June 20th. Wall Street Zen downgraded shares of Itron from a "buy" rating to a "hold" rating in a report on Saturday, September 20th. Finally, Roth Capital boosted their target price on shares of Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a report on Tuesday, July 22nd.

Insider Activity at Itron

In related news, SVP Christopher E. Ware sold 351 shares of the company's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $43,983.81. Following the transaction, the senior vice president directly owned 19,117 shares in the company, valued at approximately $2,395,551.27. This represents a 1.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Joan S. Hooper sold 970 shares of the business's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $121,550.70. Following the completion of the sale, the chief financial officer directly owned 88,394 shares of the company's stock, valued at approximately $11,076,652.14. This trade represents a 1.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 3,037 shares of company stock worth $380,566 in the last three months. 1.45% of the stock is owned by insiders.

Institutional Trading of Itron

A number of hedge funds have recently added to or reduced their stakes in the company. Invesco Ltd. boosted its holdings in Itron by 2.7% during the first quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company's stock worth $242,076,000 after buying an additional 59,962 shares in the last quarter. Geode Capital Management LLC increased its position in Itron by 2.0% during the second quarter. Geode Capital Management LLC now owns 1,109,851 shares of the scientific and technical instruments company's stock worth $146,107,000 after purchasing an additional 21,925 shares during the last quarter. Handelsbanken Fonder AB increased its position in Itron by 21.2% during the second quarter. Handelsbanken Fonder AB now owns 943,564 shares of the scientific and technical instruments company's stock worth $124,201,000 after purchasing an additional 165,300 shares during the last quarter. Amundi increased its position in Itron by 18.4% during the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company's stock worth $97,313,000 after purchasing an additional 144,361 shares during the last quarter. Finally, First Trust Advisors LP increased its position in Itron by 2.6% during the second quarter. First Trust Advisors LP now owns 757,719 shares of the scientific and technical instruments company's stock worth $99,739,000 after purchasing an additional 19,476 shares during the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Itron Stock Up 1.0%

ITRI opened at $123.97 on Friday. The stock has a market cap of $5.67 billion, a PE ratio of 21.19, a P/E/G ratio of 0.67 and a beta of 1.46. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. Itron has a 52 week low of $90.11 and a 52 week high of $140.04. The business's fifty day simple moving average is $125.16 and its 200 day simple moving average is $118.47.

Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business had revenue of $606.76 million for the quarter, compared to analysts' expectations of $610.36 million. During the same quarter in the prior year, the firm earned $1.21 earnings per share. The firm's revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, research analysts expect that Itron will post 5.33 earnings per share for the current fiscal year.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.